Linda Marbán

Biography

Dr. Marbán is currently serving as company's Chief Executive Officer, Co-founder of Capricor, Inc., a wholly-owned subsidiary of the company, Dr. Marbán has been with Capricor, Inc. since 2005 and became its Chief Executive Officer in 2010. From 2003 to 2009, Dr. Marbán was with Excigen, Inc., a biotechnology start-up company, where she was responsible for business development, operations, pre-clinical research, and supervising the development of gene therapy products in a joint development agreement with Genzyme Corp. While at Excigen, she also negotiated a joint development and sublicense agreement with Medtronic Corp. utilizing Excigen’s technology and supervised the building of a lab in which the work was to be performed. Dr. Marbán began her career in academic science, first at the Cleveland Clinic Foundation working on the biophysical properties of cardiac muscle. That work continued when she moved to a postdoctoral fellowship at Johns Hopkins University (“JHU”). While at JHU, she advanced to the rank of Research Assistant Professor in the Department of Pediatrics, continuing her work on the mechanism of contractile dysfunction in heart failure. Her tenure at JHU ran from 2000 to 2003. Dr. Marbán earned a Ph.D. from Case Western Reserve University in cardiac physiology. 

Research Interest

Clinical-stage biotechnology company, discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of cardiac and other serious medical conditions, cardiac cell therapy